Brain Canada and the ALS Society of Canada
For More Information
For additional information, please visit the Brain Canada Foundation website for
- Program guidelines
- Application forms
- Evaluation criteria
Together, Brain Canada and the Amyotrophic Lateral Sclerosis (ALS ) Society of Canada are pleased to announce the continuation of the Discovery Grant Program. The purpose of this program is to invest in the best possible projects that are focused on identifying causes of, or treatments for ALS and/or related neurological diseases, or research focused on avenues to maximize function, minimize disability and optimize quality of life through symptom management, and support to persons or families living with ALS.
The 2022 ALS Canada – Brain Canada Discovery Grant Program consists of two streams that will fund novel and innovative research approaches, supported by sound rationale and a feasible experimental plan:
Stream 1 : Aimed at nurturing novel ideas looking to obtain preliminary data or to pursue ideas supported by very early data signals.
Stream 2 : Aimed at funding more ambitious projects that are supported with some level of preliminary data to justify the larger investment.
Please view the Terms of Reference document attached.
For both streams, a minimum of 2 independent investigators are required, from different institutions or distinct departments within the same institution. A lead investigator must be named who will assume the administrative and financial responsibilities for the team grant. The lead investigator’s institution will be deemed the host institution for the grant and will receive the funding disbursements from Brain Canada.
Maximum Project Value
Stream 1: Up to six awards of up to $125,000 will be awarded in this cycle.
Stream 2: Up to two awards of up to $300,000 will be awarded in this cycle.
Please note that no more than 50% of the award funds can be allocated to research expenses incurred outside of Canada.
Stream 1: 24 months
Stream 2: 36 months
Applications will need to be formatted using standard fonts (Calibri-11, Arial-11, or Times Roman -12), single‐spaced, on a letter-size page with minimum margins of 0.5"/1.27 cm on all sides. The font size for figures and legends must be a minimum of 10 points. Use of a condensed font and spacing is not permitted. It is the sole responsibility of the applicant to ensure their submission adheres to these requirements and is received before the deadline.
Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.
If College-level review is required, your College will communicate its earlier internal deadlines.
Applicant to submit a copy of complete application along with a signed OR5 form to: firstname.lastname@example.org
Complete applications should be submitted via email to the ALS Canada Research Team (email@example.com), as a single PDF file. Applicants should request delivery and read receipts.
Read attached Terms of Reference document for specific application instructions.
Please submit your applications for review in the following order: 1) Cover page 2) Abstract (scientific) (limit ½ page) 3) Research Plan (limit 6 pages) 4) Figures and Tables (limit 3 pages) 5) Bibliography 6) Proposed Budget and Justification 7) Curriculum Vitae (see below for format) (limit 5 pages per CV) 8) Supporting Documents 9) Other funding currently held or applied for
|Terms of Reference||294.27 KB|